Theriva Biologics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Theriva Biologics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $6.69M.
- Theriva Biologics, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.95M.
- Theriva Biologics, Inc. stock issued during period, value, new issues for fiscal 2025 was $6.69M, a 241.33% increase from fiscal 2024.
- Theriva Biologics, Inc. stock issued during period, value, new issues for fiscal 2024 was $1.96M.
- Theriva Biologics, Inc. stock issued during period, value, new issues for fiscal 2018 was $16.92M.
- Theriva Biologics, Inc. stock issued during period, value, new issues for fiscal 2016 was $24.38M, a 42.82% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $6.69M 10-K · filed 2026-03-12 | |
| 2025-06-30 | $6.69M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $1.96M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.95M 10-Q · filed 2025-11-12 | |
| 2018-12-31 | $16.92M 10-K · filed 2020-02-20 | |
| 2016-12-31 | $24.38M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $42.64M 10-K · filed 2018-02-22 | |
| 2014-12-31 | $11.65M 10-K · filed 2017-03-02 | |
| 2013-12-31 | $12.19M 10-K · filed 2016-03-10 | |
| 2012-12-31 | $10.12M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $6.96M 10-K · filed 2013-04-16 | |
| 2010-12-31 | $885.00K 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |